Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
+6.37M
-
Total reported value, excl. options
-
$264M
-
Value change
-
+$91.7M
-
Put/Call ratio
-
0.38
-
Number of buys
-
62
-
Number of sells
-
-24
-
Price
-
$14.29
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2015
96 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2015.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 54.8M outstanding shares and own 33.75% of the company stock.
Largest 10 shareholders include FMR LLC (3.9M shares), RHO CAPITAL PARTNERS INC (2.67M shares), Sectoral Asset Management Inc (1.02M shares), BlackRock Fund Advisors (903K shares), MILLENNIUM MANAGEMENT LLC (822K shares), JENNISON ASSOCIATES LLC (654K shares), FRANKLIN RESOURCES INC (611K shares), CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD (609K shares), VANGUARD GROUP INC (538K shares), and EverPoint Asset Management, LLC (450K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.